07 jun: USA/tendens: Kina og Spanien ventes at give stigninger
07 jun: Carlsberg: Ølsalget firedobles før EM-kamp
07-06-2012 14:57:00

PRESS RELEASE: Bayer HealthCare Unveils Advances in CT Contrast Dose Management(TM) Solutions

Bayer HealthCare Unveils Advances in CT Contrast Dose Management(TM) Solutions

Powerful New Certegra(R) Informatics Workstation launched at SIIM 2012

Intended for U.S. Media Only

PR Newswire

TARRYTOWN, N.Y., June 7, 2012

TARRYTOWN, N.Y., June 7, 2012 /PRNewswire/ -- Bayer Radiology & Interventional announced the introduction of the Certegra(R) Workstation, an informatics-driven, touch--screen hub that enables time savings and improved patient care through a powerful suite of CT Contrast Dose Management(TM) applications and a new P3T(R) 2.0 operating environment. The new Workstation will be presented at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM) 2012 June 7 - 12 in Orlando, FL. Following the initial launch in the U.S. and Canada, the Workstation will be rolled out in phases in markets around the world.

The Workstation serves as a single interface for radiology technologists, enabling them to provide improved patient care from study set-up and preparation to administration of the patient's study. It will be the cornerstone of Bayer's industry-first[1] Contrast Dose Management solution and informatics platform. In establishing and uploading the patient's contrast-injection record, the Workstation imports patient data directly from the Modality Work List -- reducing manual entry errors to the patient record.

"Today's technology-driven CT suite demands timely access to reliable contrast-dose records throughout the chain of care," said Anthony Cinalli, vice president of the informatics business at Bayer Radiology & Interventional. "Enabling a single workflow-centralized interface, the Workstation allows for fewer clicks, less manual entry and greater control over the quality and consistency of patient care."

Interfacing with Medrad Stellant(R) CT injection systems, the Workstation's comprehensive suite of software options provides physicians and healthcare professionals instant access to real-time actionable CT contrast data captured at the point of care enabling benefits including:

-- Reduce sub-diagnostic studies, unnecessary rescans and associated

radiation exposure[2] [3],(P3T 2.0 for personalized CT abdominal, cardiac

and pulmonary angiography studies)

-- Enable more complete diagnostic decisions (PACS Outbound Interface)

-- Speed-up radiology report turnaround time and create greater study-volume

bandwidth (RIS and SR Outbound Interfaces)

-- Improve department performance by trending, reporting and analyzing

actionable data with pinpoint accuracy (Informatics Starter Package, and

the Data Analysis and Reporting Tool)

Bayer HealthCare will have the Certegra(R) Workstation on display at its booth at SIIM 2012 (booth #217 - 221).

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

[1] Reference on file.

[2] Presented at Society of Thoracic Radiology (2008) Poster Session; Christopher R. Deible, MD, PhD. Study supported by MEDRAD Inc.

[3] 510(k) FDA clearance number: K082905

SOURCE Bayer HealthCare

/CONTACT: Karen Sutherland, +1-973-487-2113, karen.sutherland@bayer.com or Alicia Cafardi, +1-724-940-8621, alicia.cafardi@bayer.com

/Web site: http://www.bayerhealthcare.com/

(END) Dow Jones Newswires

June 07, 2012 08:57 ET (12:57 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
25 aug
GEN
Stop nu det mobberi GW   Jeg elsker at følge den aktie, og det er så trist at du altid skal hævde di..
23
24 aug
FING-B
Sig mig.. har du slet ingen skam i livet !!.. du stjæler ENDNU ENGANG et skriv fra en anden skribent..
22
26 aug
FING-B
Når Nordea alene i deres analyse tager udgangspunkt i konkurrencesituationen flere år fremme i tiden..
18
23 aug
BAVA
Bavarian Nordic har sammen med Crucell og div. myndigheder igangsat to interessante nye forsøg med M..
18
24 aug
ZEAL
I Solothum uden for Bern i Svejts ligger en fabrik, hvor der er blevet investeret 50 mio CHF det sen..
17
23 aug
 
http://borsen.dk/nyheder/politik/artikel/1/330221/opgoerelse_viser_nye_milliarder_tabt_til_skattesvi..
15
21 aug
ZEAL
Bølgerne har gået højt her på EI’s forum siden Sanofi fredag oplyst at et mere endeligt svar på sags..
15
23 aug
DANSKE
Tro ikke på 6212 han er blot en bondeknold, der efterhånden er gået kold arme stakkels lille trold, ..
14
25 aug
ZEAL
Her kommer endnu et bud på, hvor Zealand skal hen efter en FDA godkendelse af iGlarlixi. Jeg siger k..
13
25 aug
GEN
Sådan ser jeg det bestemt heller ikke !! GW har hele tiden, på hans helt egen facon, stået ved at ha..
12

Rockwool/Jyske: Ledelsen gør klar til at fokusere på vækst igen

26-08-2016 15:15:02
Det spareprogram, som Rockwools topchef, Jens Birgersson, igangsatte sidste år, begynder så småt at nærme sig en afslutning. Og dermed kan stenuldsproducentens ..

Simcorp/CEO: Abonnementsmodel bag rekordstor ordrebog

26-08-2016 13:14:42
Softwareselskabet Simcorp kunne ved udgangen af første halvår notere sig den fedeste ordrebog i selskabets historie.Det er der en god forklaring på, lyder det f..

Aktier/middag: Genmab og Novo trækker ned inden nyt fra Yellen

26-08-2016 11:41:55
Kursfald i blandt andre Novo Nordisk og Genmab medvirker til at sætte det danske aktiemarked en smule under pres fredag middag.Markedet holder vejret op til eft..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. august 2016 08:53:09
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160826.1 - EUROWEB3 - 2016-08-28 08:53:09 - 2016-08-28 08:53:09 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x